[
  {
    "ts": null,
    "headline": "AbbVie Smashes Earnings, Bets Big On Depression Drug Bretisilocin",
    "summary": "AbbVie's strong financial results for the second quarter of 2025 were ensured by its two superstars, Rinvoq and Skyrizi. Click here to read my latest analysis.",
    "url": "https://finnhub.io/api/news?id=cd5b0e7f7073f7c6b99befc729473d98b794028f55711773ec7140c00fc76cbf",
    "source": "SeekingAlpha",
    "provider": "finnhub",
    "raw": {
      "category": "company",
      "datetime": 1756471054,
      "headline": "AbbVie Smashes Earnings, Bets Big On Depression Drug Bretisilocin",
      "id": 136571810,
      "image": "https://static.seekingalpha.com/cdn/s3/uploads/getty_images/1823932204/image_1823932204.jpg?io=getty-c-w1536",
      "related": "SPGI",
      "source": "SeekingAlpha",
      "summary": "AbbVie's strong financial results for the second quarter of 2025 were ensured by its two superstars, Rinvoq and Skyrizi. Click here to read my latest analysis.",
      "url": "https://finnhub.io/api/news?id=cd5b0e7f7073f7c6b99befc729473d98b794028f55711773ec7140c00fc76cbf"
    }
  }
]